Advertisement

Topics

Emisphere Technologies Inc EMIS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250

21:38 EDT 2 Aug 2017 | BioPortfolio Reports

Summary

Emisphere Technologies Inc Emisphere is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable biopharmaceutical products, besides new chemical entities, using its Eligen technology. Its lead product Eligen B12, is the first and only oncedaily oral prescription medical food approved in the US for treatment of vitamin b12 deficiency. The product is sold through a range of distributors, sellers, and other sources. Emisphere also uses its proprietary Eligen technology to produce novel oral formulations of therapeutic agents. The company's product pipeline includes prescription drugs and medical food products that are being developed in partnership or internally. Emisphere is headquartered in Roseland, New Jersey, the US.

Emisphere Technologies Inc EMIS Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.

GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay uptodate on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Original Article: Emisphere Technologies Inc EMIS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "Emisphere Technologies Inc EMIS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250"

Quick Search
Advertisement
 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...